Where should a vaccine be made available first?

Those exposed to the virus are more likely to support priority access to a vaccine in their own country.

Respondents in Germany who think they have been exposed to the disease – either through showing symptoms, because they might have recently been in contact with someone with the disease, or both – are more likely than the population as a whole to favur to believe that their country should have priority access to a vaccine developed there. As the severity of exposure increase, so too does this likelihood. What about you? Do you think any country should have priority access to a vaccine? Should it be made available to the places with the worst infection rates first? Or should it be made available everywhere? Let us know by taking the survey.